IGHE and neoplasm: A similar approach has been recently used by a group at Massachusetts Institute of Technology that showed that IgE targeting a surface tumor antigen could not successfully control the tumor growth in B16-OVA and MC-38 models in C57BL/6 wild-type mice (28).